Group 1 - The core viewpoint is that the A-share listed chain pharmacy sector is expected to expand, with Kangbaijia Pharmaceutical Group initiating its IPO guidance [1][2] - Kangbaijia operates over 2,000 stores, primarily concentrated in Fujian, Zhejiang, and Jiangxi, with Fujian being its main base [1][2] - The IPO guidance is planned to be completed between March and May 2026, indicating a potential application for IPO next year if all goes well [2] Group 2 - The chain pharmacy industry has faced challenges, including a slowdown in consumer growth, leading to a significant reduction in retail pharmacies, with over 14,000 stores closing in Q4 2024 [2] - Major chain pharmacies have experienced substantial profit declines, exemplified by Laobaixing's net profit dropping over 20% year-on-year in the first half of 2025 [2] - Despite industry challenges, Kangbaijia continues to expand through acquisitions, recently acquiring 100% stakes in two companies for a total of 100 million yuan, thereby increasing its market presence in Zhejiang [3]
A股连锁药房IPO项目来了：康佰家启动辅导
Hua Er Jie Jian Wen·2025-10-27 10:57